Circulating Matrix Metalloproteinase-2 Invades the Heart and Causes Heart Failure

被引：0
|
作者：
Prado, Alejandro F.
Azevedo, Aline
Prado, Cibele M.
Pernomian, Larissa
Pernomian, Laena
Rizzi, Elen
Castro, Myrella L.
Ramos, Simone G.
Tanus-Santos, Jose E.
Gerlach, Raquel F.
机构：
来源：
HYPERTENSION | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P108
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prolargin and matrix metalloproteinase-2 in heart failure after heart transplantation and their association with haemodynamics
    Ahmed, Abdulla
    Ahmed, Salaheldin
    Arvidsson, Mattias
    Bouzina, Habib
    Lundgren, Jakob
    Radegran, Goran
    [J]. ESC HEART FAILURE, 2020, 7 (01): : 224 - 235
  • [2] Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute Decompensated Heart Failure
    Ferreira, Joao Pedro
    Santos, Mario
    Oliveira, Jose Carlos
    Marques, Irene
    Bettencourt, Paulo
    Carvalho, Henrique
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2015, 104 (04) : 308 - 313
  • [3] Levosimendan Use Reduces Matrix Metalloproteinase-2 in Patients with Decompensated Heart Failure
    Dimitrios N. Tziakas
    Georgios K. Chalikias
    Helen I. Hatzinikolaou
    Dimitrios A. Stakos
    Nikolaos Papanas
    Ioannis K. Tentes
    Alexandros X. Kortsaris
    Efstratios Maltezos
    Dimitrios I. Hatseras
    Juan Carlos Kaski
    [J]. Cardiovascular Drugs and Therapy, 2005, 19 : 399 - 402
  • [4] Levosimendan use reduces matrix metalloproteinase-2 in patients with decompensated heart failure
    Tziakas, DN
    Chalikias, GK
    Hatzinikolaou, HI
    Stakos, DA
    Papanas, N
    Tentes, IK
    Kortsaris, AX
    Maltezos, E
    Hatseras, DI
    Kaski, JC
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (06) : 399 - 402
  • [5] Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure
    George, J
    Patal, S
    Wexler, D
    Roth, A
    Sheps, D
    Keren, G
    [J]. AMERICAN HEART JOURNAL, 2005, 150 (03) : 484 - 487
  • [6] Role of matrix metalloproteinase-2 isoforms in diabetic heart
    Lee, H. W.
    Lee, S. J.
    Lee, M. Y.
    Song, S. H.
    Ahn, J. H.
    Park, J. S.
    Oh, J. H.
    Choi, J. H.
    Lee, H. C.
    Cha, K. S.
    Hong, T. J.
    Park, M. H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 593 - 593
  • [7] Assessment of the role of matrix metalloproteinase-2 gene polymorphism in the development of chronic heart failure
    Teplyakov, A. T.
    Berezikova, E. N.
    Shilov, S. N.
    Grakova, E. V.
    Torim, Yu. Yu.
    Efremov, A. V.
    Safronov, I. D.
    Pustovetova, M. G.
    Karpov, R. S.
    [J]. TERAPEVTICHESKII ARKHIV, 2015, 87 (04): : 8 - 12
  • [8] Regulation of matrix metalloproteinase-2 in the heart by caveolin-1
    Chow, A. K.
    Cena, J.
    El-Yazbi, A. F.
    Crawford, B. D.
    Holt, A.
    Cho, W. J.
    Daniel, E. E.
    Schulz, R.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S117 - S117
  • [9] Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats
    Gang CHENG~2
    [J]. Acta Pharmacologica Sinica, 2007, (04) : 511 - 517
  • [10] INTRAVENOUS NICORANDIL THERAPY REDUCES MATRIX METALLOPROTEINASE-2 IN PATIENTS WITH ACUTE HEART FAILURE SYNDROMES
    Kunishige, Megumi
    Ishizuka, Shuichi
    Ikeoka, Kuniyasu
    Matsuo, Akiko
    Ichikawa, Minoru
    Nishibe, Akira
    Nakagawa, Yusuke
    Kijima, Yoshiyuki
    Hata, Takeshi
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E257 - E257
12345